Therapy of Wilson disease;Therapie des Morbus Wilson

Zeitschrift fur Gastroenterologie

Volumn 37, Issue 4, 1999, Pages 293-300

  Smolarek, C ^a   Stremmel, W ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Copper metabolism; D penicillamine; Liver transplantation; Therapy; Trientine; Wilson disease; Zinc

Indexed keywords

CERULOPLASMIN; CHELATING AGENT; COPPER; PENICILLAMINE; TRIENTINE; ZINC;

ADOLESCENT; ADULT; BLOOD; CHILD; FEMALE; GENETICS; HUMAN; LIVER TRANSPLANTATION; MALE; METABOLISM; REVIEW; WILSON DISEASE;

ADOLESCENT; ADULT; CERULOPLASMIN; CHELATING AGENTS; CHILD; COPPER; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; LIVER TRANSPLANTATION; MALE; PENICILLAMINE; TRIETHYLENETETRAMINE; ZINC;

EID: 0033112911     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Sternlieb I. Wilson's disease. In: Schiff L, Schiff RR (eds.). Diseases of the liver. 7th ed. Philadelphia. Lippincott, 1993
2. Bull PC, Thomas GR, Rommens JM et al. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nature Genet 1993; 5: 327
3. Chernov I, Devoto M, Brzustowicz LM et al. Mapping, cloning and genetic characterzation of the region containing the Wilson disease gene. Nature Genet 1993; 5: 338
4. Tanzi RE, Petrukhin K, Chernov I et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 1993; 5: 344
5. Yamaguchi Y, Heiny ME, Gitlin JD. Isolation and characterization of a human liver cDNA as a candidate for Wilson disease. Biochem Biophys Res Commun 1993; 197: 271
6. Liang TJ. Identification of the Wilson's disease gene: Clues for disease pathogenesis and the potential for molecular diagnosis. Hepatology 1994; 20: 329
7. Stremmel W. Pathogenese des Morbus Wilson. Z Gastroenterol 1992; 30: 199
8. Brewer GJ, Yuzbasiyan-Gurkan V. Wilson disease. Medicine 1992; 71: 139
9. Yarze JC, Martin P, Munoz SJ, Friedman IS. Wilson's disease: Current status. Am J Med 1992; 92: 643
10. Stromeyer FW, Ishak KG. Histology of the liver in Wilson' s disease: A study of 34 cases. Am J Clin Path 1960; 73: 12
11. Davies SE, Williams R, Portmann B. Hepatic morphology and histochemistry of Wilson' s disease presenting as fulminant hepatic failure: A study of 11 cases. Histopathology 1989; 15: 385
12. Oder W, Grimm G, Kollegger H et al. Neurological and neuropsychiatrie spectrum of Wilson's disease: A prospective study of 45 cases. J Neurol 1991; 238: 281
13. Stremmel W, Meyerrose KW, Niederau C et al. Wilson disease: Clinical presentation, treatment, and survival. Ann Int Med 1991; 115: 720
14. Topaloglu H, Gueuyener K, Orkun C, Renda Y. Tremor of tongue and dysarthria as the sole manifestation of Wilson's disease. Clin Neurol Neurosurg 1990; 92: 295
15. Akil M, Schwarzt JA, Dutehak D et al. The psychiatric presentations of Wilson' s disease. J Neuropsychiatry Clin Neurosci 1991; 3: 377
16. Demirkiran M, Jankovioc J, Lewis RA, Cox DW. Neurologic presentation of Wilson disease without Kayser-Fleischer rings. Neurology 1996; 46: 1040
17. Stremmel W, Niederau C, Strohmeyer G. Genetisch determinierte Lebererkrankungen, Teil II: Morbus Wilson. DIA-GM 1990; 10: 953
18. Sternlieb I. The outlook for the diagnosis of Wilson's disease. J Hepatol 1993; 17: 263
19. Grimm G, Madl C, Katzenschlager R et al. Detailed evaluation of evoked potentials in Wilson's disease. Electroencephalogr Chi Neurophysiol 1992; 82: 119
20. Martin da Costa C, Baldwin D, Portmann B et al. Value of urinary copper excretion alter penicillaniine challenge in the diagnosis of Wilson's disease. Hepatology 1992; 5: 609
21. Ludwig J, Moyer TP, Rakela J. The liver biopsy diagnosis of Wilson's disease. Methods in pathology. AJCP 1991; 102: 443
22. Bermann DH, Levonthal RI, Gavaler JS et al. Clinical differentiation of fulminant Wilson hepatitis from other causes of hepatic failure. Gastroenterology 1991; 100: 1129
23. Sallie R, Katsiyiannakis L, Baldwin D, Davies S et al. Failure of simple biochemical indexes to reliably differentiate fulminant Wilson's disease from other causes of fulminant liver failure. Hepatology 1992; 16: 1206
24. Teratologic evaluation of FDA 71-49 (zinc sulfate). Food ad Drug Administration. Food and Drug Research Laboratories, Inc. Prepared for Food and Drug Administration. United States Department of Commerce Publications PD-221 805. February 1973. and PB 267. June 1974
25. Berghella V, Steele D, Spector T, Cambi F, Johnson A. Successful pregnancy in an neurologically impaired woman with Wilson's disease. Am J Obstet Gynecol 1997; 176: 712
26. Walshe JM, Penicillamine. A new oral therapy for Wilson's disease. Am J Med 1956; 21: 487
27. Scheinberg IH, Sternlieb I, Schilsky M, Stockert RJ. Penicillamine may detoxify copper in Wilson's disease. Lancet 1987; 2: 95
28. Scheinberg IH, Sternlieb I. Wilson's disease. In: Smith LH Jr. (ed.) Major problems in internal medicine, (vol 23) Philadelphia, WB Saunders Co., 1984
29. Gollari JL. Copper metabolism, Wilson's disease and hepatic copper toxicosis. In: Zakim D, Boyer TD (eds.). Hepatology: A textbook of liver disease, 2nd ed. Philadelphia. WB Saunders, 1990, 1249
30. Walshe JM. The liver in Wilson's disease (hepatolenticular degeneration). In: Schiff L, Schiff ER (eds.). Diseases of the liver 6th. ed. Philadelphia. JB Lippincott, 1987, 1037
31. Brewer GJ. Fractal recommendations and new therapies for Wilsons disease. Drugs 1995; 50: 240
32. Mardsen CD. Wilson's disease. Q J Med 1987; 248: 959
33. Brewer GJ, Terry CA, Aisen AM et al. Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy. Arch Neurol 1987; 44: 490
34. Scheinherg IH, Sternlieb I. Wilson's disease. In: Smith LH Jr (ed.). Major problems in internal medicine. Vol. 23. Philadelphia. WB Saunders Company, 1984
35. Owen CA Jr. Wilson's disease: The etiology, clinical aspects and treatment of inherited copper toxicosis. New Jersey. Noyes Publications, 1981
36. Sozeri E, Feist D, Ruder II, Scharer K, Proteinuria and other renal functions in Wilson's disease. Pediatr Nephrol 1997; 11: 307
37. Dubois RS, Rodgerson DO, Slovis TL, Hambidge KM, Bianchi TA. Triethylene tetramine dihydrochloride in Wilson's disease (letter). Lancet 1970; 2: 775
38. Walshe JM. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride. Q J Med 1973; 42: 441
39. Walshe JM. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride. Lancet 1982; 1: 643
40. Dahlmann T, Hartvig F, Lofholm M et al. Long-term treatment of Wilson's disease with triethylene tetramine dihydrochloride (trientine). QJM 1995; 88: 609
41. Morita J, Yoshino M, Watari H, Yoshida I et al. Wilson's disease treatment by triethylene tetramine dihydrochloride (trientine 2-HCI): Long-term observations. Dev Pharmacol Ther 1992; 19: 6
42. Hoogenraad TU, Koevoet R, De Ruyter Korver EGWM. Oral zinc sulfate as long-term treatment in Wilson's disease (hepatolenticular degeneration). Eur Neurol 1979; 18: 205
43. Brewer GJ, Yuzbasiyan-Gurkan V, Lee DY et al. The treatment on Wilson's disease with zinc: VI. Initial treatment studies. J Lab Clin Med 1989; 114: 633
44. Hoogenraad TU, Van Hattum J, Van den Hammer CJA. Management of Wilson's disease with zinc sulfate: Experience in a series of 27 patients. J Neurol Sci 1987; 77: 137
45. Yuzbasiyan-Gurkan V, Grider A, Nostrant V et al. Treatment of Wilson's disease with zinc: X. Intestinal metallothionein induction. J Lab Clin Med 1992; 12: 380
46. Brewer GJ, Hill GJ, Prasad AS et al. Treatment of Wilson's disease with zinc. Ann Intern Med 1983; 99: 314
47. Lee DY, Brewer GJ, Wang Y. The treatment of Wilson's disease with zinc: VII. Protection of the liver from copper toxicity by zinc induced metallothionein in rat model. J Lab Clin Med 1989; 114: 639
48. Brewer GJ, Yuzbasiyan-Gurkan V, Johnson V et al. Treatment of Wilson's disease with zinc: XII. Dose regimen requirements. Am J Med Sci 1993; 305: 199
49. Brewer GJ, Yuzbasiyan-Gurkan V, Dirk R. Zinc therapy of Wilson's disease: VIII. Dose response studies. J Trace Elem Exp Med 1990; 3: 227
50. Schölmerich J, Freudemann A, Kottgen E et al. Biovailability of zinc as zinc-histidine complexes. A comparison with zinc-sullate in healthy men. Am J Chir Nutr 1987; 45: 1480
51. Yuzbasiyan-Gurkan V, Brewer GJ, Abrams GD et al. Treatment of Wilson's disease with zinc: V. Changes in serum levels of lipase, amylase and alkaline phospatase in Wilson's disease patients. J Lab Clin Med 1989; 114: 520
52. Brewer GJ, Yuzbasiyan-Gurkan V, Johnson V. Treatment of Wilson's disease with zinc: IX. Response of serum lipids. J Lab Clin Med 1991; 118: 199
53. Brewer GJ, Johnson V, Kaplan J. Treatment of Wilson's disease with zinc: XIV. Studies of the effect of zinc on lymphocyte function. J Lab Clin Med 1997; 129: 649
54. Brewer GJ, Hill GM, Prasad AS et al. The treatment of Wilson's disease with zinc: IV. Efficacy monitoring using urine and plasma copper. Proc Soc Exp Biol Med 1987; 7: 446
55. Kreuzpaintner G, Lauchart W, Frenzel H et al. Orthotope Lebertransplantation bei Morbus Wilson und akuter Leberinsuffizienz. Dtsch Med Wochenschr 1988; 113: 1256
56. Sehilsky ML, Scheinberg IH, Sternlieb I. Liver transplantation for Wilson's disease: Indications and outcome. Hepatology 1994; 19: 583
57. Sternlieb I. Wilson's disease: Indications for liver transplants. Hepatology 1984; 4 (suppl): 15S
58. Rela M, Heaton ND, Vougas V, McEntee G et al. Orthotopic liver transplantation for hepatic complications of Wilson's disease. Br J Surg 1993; 80: 909
59. Schumacher G, Platz KP, Mueller AR et al. Liver transplantation: Treatment of choice for hepatic and neurological manifestation of Wilson's disease. Clin Transplant 1997; 11: 217
60. Devlin J, Wendon J, Heaton N, Tan KC, Wiliams R. Pretransplantation clinical status and outcome for emergency transplantation for acute liver failure. Hepatology 1995; 21: 1018
61. Bullary S, Hassanein T, Van Thiel DH. Liver transplantation for Wilson's disease. J Hepatol 1995; 23: 373
62. Schumacher G, Platz KP, Mueller AR et al. Die neurologische Manifestation des Morbus Wilson als Indikation zur Lebertransplantation (Abstrakt). Z Gastroenterol 1996; 34: 76
63. Chen GL, Chen YS, Lui CC, Hsu SP. Neurological improvement of Wilson's disease after liver transplantation. Transplant Proc 1997; 29: 497
64. Schumacher G, Mueller AR, Platz KP, Neuhaus R et al. Neurologic symptoms improve in patients with Wilson's disease despite immunosuppression. Transplant Proc 1996; 28: 3099